These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14252943)

  • 1. A NEW APPROACH TO THROMBOEMBOLIC DISEASE.
    KAPPERT A; MONTIGEL C
    Vasc Dis; 1965 Jan; 2():39-42. PubMed ID: 14252943
    [No Abstract]   [Full Text] [Related]  

  • 2. [SOME BLOOD COAGULATION FACTORS IN PATIENTS WITH CANCER OF THE STOMACH AND ESOPHAGUS].
    ISAKHANOV PM; LAPIN MD
    Khirurgiia (Mosk); 1963 Aug; 39():88-92. PubMed ID: 14087769
    [No Abstract]   [Full Text] [Related]  

  • 3. [ASSESSMENT OF THE INSECTICIDAL ACTION OF SOME PYRAZOLONE DERIVATIVES].
    FAVOROVA LA; DOLGOV GF
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Jul; 40():7-11. PubMed ID: 14070209
    [No Abstract]   [Full Text] [Related]  

  • 4. [OUR EXPERIENCES WITH LASTING ANTICOAGULANT THERAPY].
    GORTVAI G; ADL M; KOVACS M
    Orv Hetil; 1964 Mar; 105():607-10. PubMed ID: 14138712
    [No Abstract]   [Full Text] [Related]  

  • 5. DRUG-INDUCED INCREASE OF PROTHROMBIN COMPLEX ACTIVITY IN VIVO.
    WEINER M; DAYTON PG
    Am J Med Sci; 1964 Jan; 247():75-83. PubMed ID: 14106883
    [No Abstract]   [Full Text] [Related]  

  • 6. EFFECT OF ANIMAL AND VEGETABLE FATS ON BLOOD COAGULATION IN HYPERTENSION PATIENTS.
    ALFEROVA LN
    Fed Proc Transl Suppl; 1963; 22():1143-6. PubMed ID: 14079320
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 8. LONG-TERM EFFECTS OF INTERMITTENT LOW DOSES OF HEPARIN ON PLATELET ECONOMY IN MAN.
    MUSTARD JF; GILBERT JB; MURPHY EA
    Lancet; 1965 Mar; 1(7385):575-6. PubMed ID: 14250082
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of heparin therapy: Controlled prospective trial.
    Salzman EW; Deykin D; Shapiro RM; Rosenberg R
    N Engl J Med; 1975 May; 292(20):1046-50. PubMed ID: 1091856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin.
    Zucker S; Cathey MH
    J Lab Clin Med; 1969 Feb; 73(2):320-6. PubMed ID: 5764028
    [No Abstract]   [Full Text] [Related]  

  • 11. TREATMENT OF THE PATIENT WITH GOUT.
    DENKO CW
    Ohio State Med J; 1963 Nov; 59():1098-101. PubMed ID: 14083462
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic drugs: part I.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(1):41-68. PubMed ID: 789043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [OUR EXPERIENCE WITH THE OWREN TEST].
    CASTRO CM; GROIS J; GRILLI H; DESOLDATI L
    Dia Med; 1963 Nov; 35():1854-9. PubMed ID: 14099799
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring heparin therapy with the activated partial thromboplastin time.
    Stuart RK; Michel A
    Can Med Assoc J; 1971 Mar; 104(5):385-8. PubMed ID: 5557913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE EFFECT OF PHENYLBUTAZONE AND ITS DERIVATIVES OXYPHENBUTAZONE AND SULFINPYRAZONE ON S-35-SULFATE INCORPORATION IN CARTILAGE AND STOMACH.
    DENKO CW
    J Lab Clin Med; 1964 Jun; 63():953-8. PubMed ID: 14179130
    [No Abstract]   [Full Text] [Related]  

  • 16. [EFFECT OF CORCHOROZIDE ON THE THROMBOPLASTIN AND HEPARIN TIME IN RABBITS UNDER NORMAL CONDITIONS AND IN EXPERIMENTAL MYOCARDITIS].
    KITAEVA RI
    Farmakol Toksikol; 1964; 27():179-83. PubMed ID: 14193081
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of monitoring heparin therapy in the prevention of recurrence in patients with venous thromboembolic disease.
    Hirsh J
    Thromb Diath Haemorrh Suppl; 1973; 56():181-90. PubMed ID: 4805494
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations.
    Rhodes GR; Dixon RH; Silver D
    Surg Gynecol Obstet; 1973 Mar; 136(3):409-16. PubMed ID: 4688805
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of action and monitoring of anticoagulants.
    Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):1-11. PubMed ID: 3961504
    [No Abstract]   [Full Text] [Related]  

  • 20. [EXPERIENCE IN THE CLINICAL USE OF FIBRINOLYSIN].
    PANCHENKO VM; ANDREENKO GV
    Ter Arkh; 1964 Jan; 36():43-51. PubMed ID: 14149444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.